Will Weinstein Appointed to Hansen Medical-s Board of Directors
Company-s Board Gains Valuable Wall Street Experience
Hansen Medical to Replace Current Debt Facility With New $33 Million, Interest-Only Debt Facility Through 2017
Will Provide Additional Liquidity of Nearly $25 Million Over Next 30 Months Compared to Current Debt Facility; Upon Closing and Funding of This New Debt Agreement, the Company Will Withdraw Its ATM Facility Which Was Not Drawn on or Used
Hansen Medical Announces Initiation of Sell-Side Coverage by Cowen and Company
MOUNTAIN VIEW, CA — (Marketwired) — 06/26/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that Cowen and Company has initiated sell-side coverage of Hansen Medical. The report was authored by Joshua Jennings, M.D., Director and Senior Research Analyst for medical devices.Hansen Medical is followed by several analysts, including Cowen and Company. Any opinions, estimates, forecasts or statements regarding Hansen Medical-s performance made b
Hansen Medical Announces Initiation of Sell-Side Coverage by Wm Smith & Co.
MOUNTAIN VIEW, CA — (Marketwired) — 06/25/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that Wm Smith & Co. has initiated sell-side coverage of Hansen Medical. The report was authored by Sherry Grisewood, CFA.Hansen Medical is followed by several analysts, including Wm Smith & Co. Any opinions, estimates, forecasts or statements regarding Hansen Medical-s performance made by Wm Smith & Co. or other analysts are theirs alone a
Hansen Medical to Exhibit Magellan(TM) Robotic System at 2013 Vascular Annual Meeting(R) of the Society for Vascular Surgery
MOUNTAIN VIEW, CA — (Marketwired) — 05/23/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will exhibit its Magellan Robotic System at the 2013 Vascular Annual Meeting® of the Society for Vascular Surgery from May 30 – June 1 at the Moscone West Convention Center in San Francisco, CA. The Company will be exhibiting the Magellan Robotic System and conducting product demonstrations at Booth 301."We are excited to showcase our
Hansen Medical Announces Agreement in Principle to Settle Securities Class Action
MOUNTAIN VIEW, CA — (Marketwired) — 05/08/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that the Company has reached an agreement in principle to settle the consolidated securities class-action lawsuit related to the restatement of Hansen Medical-s financial statements that was first announced in October 2009. Upon final court approval, all defendants, including Hansen Medical, will receive a full and complete release of all claims in th
Hansen Medical-s Magellan(TM) Robotic System Scheduled to Be Utilized in Five Live Cases at EuroPCR 2013
MOUNTAIN VIEW, CA — (Marketwired) — 05/07/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that its Magellan Robotic System is scheduled to be utilized in several live cases to be broadcast at EuroPCR 2013, which takes place May 21 – May 24 in Paris, France. Professor Jean-Pierre Becquemin, Professor Hicham Kobeiter, Professor P. Desgranges, and Dr. Frédéric Cochennec are scheduled to use the Magellan System in five complex en
Hansen Medical to Exhibit Magellan(TM) Robotic System at 8th Annual European Symposium of Vascular Biomaterials in France
MOUNTAIN VIEW, CA — (Marketwired) — 05/06/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will be exhibiting its Magellan Robotic System at the 8th Annual European Symposium of Vascular Biomaterials (ESVB) from Friday, May 10th to Monday, May 13th at the Strasbourg Hilton in Strasbourg, France. The Company-s Magellan Robotic System is installed at Hôpital Civil Strasbourg and has been utilized in numerous successful cases sin
Pre-Clinical Study and Initial Clinical Experience Highlight Potential Benefits of Hansen Medical-s Robotic Technology in Treating Carotid Arteries
Study Results Published in Journal of Cardiovascular Surgery
Hansen Medical Announces First Quarter 2013 Results Conference Call
MOUNTAIN VIEW, CA — (Marketwired) — 04/30/13 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will release its financial and operating results for the first quarter ended March 31, 2013 after market close on Wednesday, May 8, 2013.Bruce Barclay, President and Chief Executive Officer, will host a conference call at 5:00 p.m. ET (2:00 p.m. PT) on May 8, 2013 to discuss the company-s results. The call may be accessed by dialing 877-941-14